About Motile sperm domain-containing protein 2
Motile sperm domain-containing protein 2 (MOSPD2) is a protein
from Homo sapiens identified by UniProt accession
Q8NHP6, 518 residues long.
MolForge cross-references it against 0 known binders and
21 disease associations.
Target properties
| Protein name | Motile sperm domain-containing protein 2 |
| UniProt accession | Q8NHP6 |
| Gene | MOSPD2 |
| Organism | Homo sapiens |
| Length | 518 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (21)
Diseases linked to this target (Open Targets).
- experimental autoimmune encephalomyelitis · score 0.07
- metastatic melanoma · score 0.02
- neoplasm · score 0.02
- infection · score 0.02
- infect · score 0.02
- cancer · score 0.01
- myeloid sarcoma · score 0.01
- Infertility · score 0.01
- osteosarcoma · score 0.01
- Osteoporosis · score 0.00
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q8NHP6-F1 | alphafold | PREDICTED | 80.22 | — |
Amino-acid sequence (518 residues)
MAENHAQNKA KLISETRRRF EAEYVTDKSD KYDARDVERL QQDDNWVESY LSWRHNIVDE TLKMLDESFQ WRKEISVNDL NESSIPRWLL EIGVIYLHGY DKEGNKLFWI RVKYHVKDQK TILDKKKLIA FWLERYAKRE NGKPVTVMFD LSETGINSID MDFVRFIINC FKVYYPKYLS KIVIFDMPWL MNAAFKIVKT WLGPEAVSLL KFTSKNEVQD YVSVEYLPPH MGGTDPFKYS YPPLVDDDFQ TPLCENGPIT SEDETSSKED IESDGKETLE TISNEEQTPL LKKINPTEST SKAEENEKVD SKVKAFKKPL SVFKGPLLHI SPAEELYFGS TESGEKKTLI VLTNVTKNIV AFKVRTTAPE KYRVKPSNSS CDPGASVDIV VSPHGGLTVS AQDRFLIMAA EMEQSSGTGP AELTQFWKEV PRNKVMEHRL RCHTVESSKP NTLTLKDNAF NMSDKTSEDI CLQLSRLLES NRKLEDQVQR CIWFQQLLLS LTMLLLAFVT SFFYLLYS
Explore Motile sperm domain-containing protein 2 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets